DEBORAH GRAVES: Open Payments
NPI 1841404035 · HUMBOLDT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 29 payments from 9 companies in 2025. Trend: 2023 $326 · 2024 $494 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $250 |
| ABBVIE INC. | 10 | $191 |
| AstraZeneca Pharmaceuticals LP | 1 | $104 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Lundbeck LLC | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Organon LLC | 1 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| Medline Industries LP | 1 | $14 |
Products named: REXULTI, VRAYLAR, AIRSUPRA, Auvelity, CAPLYTA, NEXPLANON, VIBERZI, UBRELVY.
Industry payments across TN — which companies pay providers there.
